Fernando J Bianco

Summary

Publications

  1. ncbi request reprint Radical prostatectomy: surgical planning, execution, and outcomes
    Fernando J Bianco
    Department of Surgery, George Washington University, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Urol Rep 9:231-6. 2008
  2. ncbi request reprint Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods
    Ofer Yossepowitch
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 178:493-9; discussion 499. 2007
  3. pmc Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur Urol 53:960-6. 2008
  4. pmc Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria
    Fernando P Secin
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Department of Epidemiology and Biostatistics AC, AJV, Memorial Sloan Kettering Cancer Center, New York, New York
    J Urol 181:609-13; discussion 614. 2009
  5. ncbi request reprint The surgical learning curve for prostate cancer control after radical prostatectomy
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Natl Cancer Inst 99:1171-7. 2007
  6. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
  7. pmc Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
    Ofer Yossepowitch
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur Urol 53:950-9. 2008
  8. ncbi request reprint Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
  9. ncbi request reprint Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer
    Fernando J Bianco
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 69:343-6. 2007
  10. ncbi request reprint Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:448-53. 2005

Collaborators

Detail Information

Publications39

  1. ncbi request reprint Radical prostatectomy: surgical planning, execution, and outcomes
    Fernando J Bianco
    Department of Surgery, George Washington University, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Urol Rep 9:231-6. 2008
    ..Research is needed to identify the most effective technical steps that can be taught through formal educational programs...
  2. ncbi request reprint Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods
    Ofer Yossepowitch
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 178:493-9; discussion 499. 2007
    ..Of patients undergoing radical prostatectomy we identified those at high risk based on 8 previously described definitions. We examined pathological characteristics and prostate specific antigen outcomes...
  3. pmc Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur Urol 53:960-6. 2008
    ..We previously demonstrated that there is a learning curve for open radical prostatectomy. We sought to determine whether the effects of the learning curve are modified by pathologic stage...
  4. pmc Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria
    Fernando P Secin
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers and Department of Epidemiology and Biostatistics AC, AJV, Memorial Sloan Kettering Cancer Center, New York, New York
    J Urol 181:609-13; discussion 614. 2009
    ..We applied the European Society of Urological Oncology algorithm to an independent data set to determine its predictive value...
  5. ncbi request reprint The surgical learning curve for prostate cancer control after radical prostatectomy
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Natl Cancer Inst 99:1171-7. 2007
    ..We analyzed the surgical learning curve for prostate cancer recurrence after radical prostatectomy...
  6. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
    ..Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy...
  7. pmc Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy
    Ofer Yossepowitch
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur Urol 53:950-9. 2008
    ..We assessed how accurately these definitions identify patients likely to receive secondary cancer therapy, experience metastatic progression, or die of prostate cancer...
  8. ncbi request reprint Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
    ..Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression...
  9. ncbi request reprint Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer
    Fernando J Bianco
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 69:343-6. 2007
    ....
  10. ncbi request reprint Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 62:448-53. 2005
    ..We report the long-term cancer control associated with salvage RP in a consecutive cohort of patients and identify the variables associated with disease progression and cancer survival...
  11. pmc Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 128:1697-702. 2011
    ..Although our findings have no direct clinical implications, studies investigating biological variables as predictors of outcome after curative resection of cancer should consider the impact of surgeon-specific factors...
  12. pmc Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?
    Andrew J Vickers
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 106:576-80. 2006
    ..In the current study, the authors evaluated whether time from biopsy to radical prostatectomy (RP) was predictive of postoperative biochemical disease recurrence (BCR)...
  13. pmc Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 23:7005-12. 2005
    ..We have updated the nomogram by extending the predictions to 10 years after RP and have enabled the nomogram predictions to be adjusted for the disease-free interval that a patient has maintained after RP...
  14. ncbi request reprint Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy
    Fernando P Secin
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 106:2369-75. 2006
    ....
  15. pmc Variations among experienced surgeons in cancer control after open radical prostatectomy
    Fernando J Bianco
    Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 183:977-82. 2010
    ..This excessive variation is known as heterogeneity. We explored whether there is also heterogeneity among high volume surgeons with respect to cancer control after surgery...
  16. pmc The clinical features of anterior prostate cancers
    Theresa M Koppie
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 98:1167-71. 2006
    ..To identify the clinical characteristics of anterior prostate cancers (APCs) and to compare these with posterior prostate cancers (PPCs)...
  17. ncbi request reprint Robotic radical prostatectomy: present and future
    Fernando J Bianco
    Columbia University, New York, NY, USA
    Arch Esp Urol 64:839-46. 2011
    ..If the latter objective is reached, urologic robotic surgeons will deliver counseling based on clinical evidence delivering major progress for our Urology field...
  18. ncbi request reprint Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer
    Brett S Carver
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 176:564-8. 2006
    ..We evaluated patients at our institution who underwent radical prostatectomy for clinical stage T3 prostate cancer to determine their long-term clinical outcomes...
  19. ncbi request reprint Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Stephen A Boorjian
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 96:773-6. 2005
    ....
  20. ncbi request reprint The anterior layer of Denonvilliers' fascia: a common misconception in the laparoscopic prostatectomy literature
    Fernando P Secin
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York 10021, USA
    J Urol 177:521-5. 2007
    ..To address this inconsistency we performed a detailed anatomical study of tissue planes encountered during laparoscopic dissection of the posterior bladder neck...
  21. ncbi request reprint Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience
    Fernando P Secin
    Departments of Urology and Plastic Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 177:664-8. 2007
    ..We determined the success rate and identified determinants of success of bilateral cavernous nerve grafting following resection of the 2 nerves during radical prostatectomy in patients who were potent preoperatively...
  22. pmc The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer
    Timothy A Masterson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 175:1320-4; discussion 1324-5. 2006
    ....
  23. ncbi request reprint Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    BJU Int 94:1210-2. 2004
  24. ncbi request reprint Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 172:2239-43. 2004
    ..We report the morbidity associated with salvage RP in 100 consecutive patients...
  25. ncbi request reprint The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies
    William C Huang
    Departments of Urology, Biostatistics Epidemiology and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 177:1324-9; quiz 1591. 2007
    ..We characterized and mapped the prostate cancers in our series of whole mount salvage radical prostatectomy specimens...
  26. pmc Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters
    Fernando J Bianco
    Departments of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 173:2099-103. 2005
    ..While better outcomes are associated with high volume surgeons, the degree of variation in outcomes among surgeons has not been fully examined...
  27. ncbi request reprint Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer
    Fernando P Secin
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
    Eur Urol 51:764-71. 2007
    ..Our objective was to determine preoperative risk factors and the association of ipsilateral degree of neurovascular bundle dissection (intraoperative factor) with side-specific PSMs in these patients...
  28. ncbi request reprint African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram
    Brent V Yanke
    State University of New York Downstate Medical Center, New York, NY, USA
    BJU Int 98:783-7. 2006
    ....
  29. ncbi request reprint Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")
    Fernando J Bianco
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 66:83-94. 2005
    ..Cancer control was good even for patients with adverse prognostic features. The probability of death from cancer was similar to other causes after disease progression. By 2 years, 60% of men were continent, potent, and cancer free...
  30. pmc Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    Ginger Isom-Batz
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 173:1935-7. 2005
    ..We explored the relationship between preoperative total testosterone, and pathological stage and progression in patients with clinically localized prostate cancer treated with radical prostatectomy...
  31. pmc Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading
    John F Donohue
    Department of Urology, Memorial Sloan Kettering Cancer Center, 353 East 68th Street, New York, NY 10021, USA
    J Urol 176:991-5. 2006
    ..We examined long-term outcomes in patients with high grade prostate cancer on biopsy who were treated with radical prostatectomy alone. We also investigated the impact on outcomes of changes in the radical prostatectomy Gleason score...
  32. pmc Low risk prostate cancer in men under age 65: the case for definitive treatment
    Thomas L Jang
    Division of Urology, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Urol Oncol 25:510-4. 2007
    ....
  33. pmc The natural history of noncastrate metastatic prostate cancer after radical prostatectomy
    Ofer Yossepowitch
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 51:940-7; discussion 947-8. 2007
    ..To characterise the natural history of metastatic prostate cancer after radical prostatectomy (RP) in patients followed expectantly for rising prostate-specific antigen (PSA) (noncastrate metastases)...
  34. ncbi request reprint Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis
    Shahrokh F Shariat
    Department of Urology, Weill Cornell Medical College, New York Presbyterian Hospital, NY 10021, USA
    Arch Esp Urol 64:681-94. 2011
    ..To be able to be used commercially such a panel will have to answer clinically relevant questions in a simple and cost-effective way...
  35. pmc Improved prediction of prostate cancer recurrence through systems pathology
    Carlos Cordon-Cardo
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Invest 117:1876-83. 2007
    ..This robust platform has broad applications in patient diagnosis, treatment management, and prognostication...
  36. ncbi request reprint Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection
    Brett S Carver
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Urol 176:100-3; discussion 103-4. 2006
    ..We evaluated patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell tumors to determine predictors of teratomatous elements in the retroperitoneum...
  37. doi request reprint Posterior rhabdosphincter reconstruction during robotic assisted radical prostatectomy: results from a phase II randomized clinical trial
    Douglas E Sutherland
    Department of Urology, George Washington University, Washington, DC, USA
    J Urol 185:1262-7. 2011
    ..Posterior rhabdosphincter reconstruction following radical prostatectomy was designed to improve early urinary continence. We executed a randomized clinical trial to test this conjecture in men undergoing robotic radical prostatectomy...
  38. doi request reprint Prospective intermediate follow-up of carcinoma in situ involving the distal ureter at cystectomy: is there a role for ureteroscopy?
    Kristofer R Wagner
    Department of Urology, George Washington University, Washington, District of Columbia, USA
    J Endourol 22:1241-6. 2008
    ..Management of this finding is controversial. The objective of this study was to determine if follow-up with ureteroscopy could aid in early detection of recurrences in these patients...
  39. ncbi request reprint Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy
    Andrew J Stephenson
    Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Curr Treat Options Oncol 5:357-65. 2004
    ..A long-term cure is possible for patients with locally recurrent prostate cancer after radiation therapy. Local salvage therapy must be instituted early to be successful in the course of progressive disease...